BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28430960)

  • 1. Triple-site pacing for cardiac resynchronization in permanent atrial fibrillation: follow-up results from a prospective observational study.
    Marques P; Nobre Menezes M; Lima da Silva G; Guimarães T; Bernardes A; Cortez-Dias N; Carpinteiro L; de Sousa J; Pinto FJ
    Europace; 2018 Jun; 20(6):986-992. PubMed ID: 28430960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple-site pacing for cardiac resynchronization in permanent atrial fibrillation - Acute phase results from a prospective observational study.
    Marques P; Nobre Menezes M; Lima da Silva G; Bernardes A; Magalhães A; Cortez-Dias N; Carpinteiro L; de Sousa J; Pinto FJ
    Rev Port Cardiol; 2016 Jun; 35(6):331-8. PubMed ID: 27255170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.
    Röger S; Schneider R; Rudic B; Liebe V; Stach K; Schimpf R; Borggrefe M; Kuschyk J
    Europace; 2014 Aug; 16(8):1205-9. PubMed ID: 24706089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.
    Rönn F; Kesek M; Karp K; Henein M; Jensen SM
    Europace; 2011 Dec; 13(12):1747-52. PubMed ID: 21712261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
    Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Higher Frequency of Atrial Fibrillation in Patients with Cardiac Resynchronization Therapy.
    Grbović A; Pavlović S; Žugić V
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138281
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiarrhythmic effect of cardiac resynchronization therapy with triple-site biventricular stimulation.
    Ogano M; Iwasaki YK; Tanabe J; Takagi H; Umemoto T; Hayashi M; Miyauchi Y; Mizuno K
    Europace; 2013 Oct; 15(10):1491-8. PubMed ID: 23696627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac resynchronization therapy non-responder to responder conversion rate in the more response to cardiac resynchronization therapy with MultiPoint Pacing (MORE-CRT MPP) study: results from Phase I.
    Leclercq C; Burri H; Curnis A; Delnoy PP; Rinaldi CA; Sperzel J; Lee K; Calò L; Vicentini A; Concha JF; Thibault B
    Eur Heart J; 2019 Sep; 40(35):2979-2987. PubMed ID: 30859220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using three-dimensional echocardiography to guide left ventricle lead position in cardiac resynchronization therapy: does it make any difference.
    Badran HA; Kamel JZ; Mohamed TR; Abdelhamid MA
    J Interv Card Electrophysiol; 2017 Apr; 48(3):299-306. PubMed ID: 28194611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right ventricular septal pacing as alternative for failed left ventricular lead implantation in cardiac resynchronization therapy candidates.
    Alhous MH; Small GR; Hannah A; Hillis GS; Frenneaux M; Broadhurst PA
    Europace; 2015 Jan; 17(1):94-100. PubMed ID: 25359384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does permanent atrial fibrillation modify response to cardiac resynchronization therapy in heart failure patients?
    Abreu A; Oliveira M; Silva Cunha P; Santa Clara H; Portugal G; Gonçalves Rodrigues I; Santos V; Morais L; Selas M; Soares R; Branco L; Ferreira R; Mota Carmo M;
    Rev Port Cardiol; 2017 Oct; 36(10):687-694. PubMed ID: 29031455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multipoint left ventricular pacing in a single coronary sinus branch improves mid-term echocardiographic and clinical response to cardiac resynchronization therapy.
    Pappone C; Ćalović Ž; Vicedomini G; Cuko A; McSpadden LC; Ryu K; Romano E; Baldi M; Saviano M; Pappone A; Ciaccio C; Giannelli L; Ionescu B; Petretta A; Vitale R; Fundaliotis A; Tavazzi L; Santinelli V
    J Cardiovasc Electrophysiol; 2015 Jan; 26(1):58-63. PubMed ID: 25109276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and classic echocardiographic features of patients with, and without, left ventricle reverse remodeling following the introduction of cardiac resynchronization therapy.
    Wiliński J; Czarnecka D; Wojciechowska W; Kloch-Badełek M; Jastrzębski M; Bacior B; Sondej T; Kusak P; Przybyła A; Kawecka-Jaszcz K
    Cardiol J; 2011; 18(2):157-64. PubMed ID: 21432822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
    Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
    Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation incidence and impact of biventricular pacing on long-term outcome in patients with heart failure treated with cardiac resynchronization therapy.
    Jacobsson J; Reitan C; Carlson J; Borgquist R; Platonov PG
    BMC Cardiovasc Disord; 2019 Aug; 19(1):195. PubMed ID: 31409276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No effects of cardiac resynchronization therapy and right ventricular pacing on the right ventricle in patients with heart failure and atrial fibrillation.
    Majos-Karwacka E; Kraska A; Kowalik I; Smolis-Bak E; Lipiec P; Kasprzak J; Szwed H; Dabrowski R
    Scand Cardiovasc J; 2021 Feb; 55(1):15-21. PubMed ID: 32954833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac contractility modulation treatment in patients with symptomatic heart failure despite optimal medical therapy and cardiac resynchronization therapy (CRT).
    Kuschyk J; Nägele H; Heinz-Kuck K; Butter C; Lawo T; Wietholt D; Roeger S; Gutterman D; Burkhoff D; Rousso B; Borggrefe M
    Int J Cardiol; 2019 Feb; 277():173-177. PubMed ID: 30409733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac resynchronization therapy reduces T-wave alternans in patients with heart failure.
    Hua W; Chen K; Zhou X; Dai Y; Chen R; Wang J; Ding L; Liu Z; Feng T; Yu J; Cheng J; Liu C; Zhang S
    Europace; 2015 Feb; 17(2):281-8. PubMed ID: 25398405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.
    Brignole M; Botto G; Mont L; Iacopino S; De Marchi G; Oddone D; Luzi M; Tolosana JM; Navazio A; Menozzi C
    Eur Heart J; 2011 Oct; 32(19):2420-9. PubMed ID: 21606084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiac resynchronization therapy in patients with permanent atrial fibrillation].
    Mareev IuV; Shitov VN; Kiktev VG; Sapel'nikov OV; Latypov RS; Grishin IR; Malkina TA; Nesterenko LIu; Iuricheva IuA; Sokolov SF; Saidova MA; Akchurin RS; Golitsyn SP
    Kardiologiia; 2013; 53(5):43-9. PubMed ID: 23952994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.